SCHEMBL29469708

SCHEMBL29469708

O=C(NS(=O)(=O)c1cccc2c1OCCO2)c1cc2c(F)cc(N3CC(F)C3)cc2o1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACLY P53396 1/20 0.39
HTR1A P08908 2/20 0.33
HTR4 Q13639 3/20 0.32
CHRM1 P11229 2/20 0.32
CHRM2 P08172 1/20 0.32
RRM1 P23921 1/20 0.32
RRM2B Q7LG56 1/20 0.32
ADORA2A P29274 1/20 0.31
ADORA1 P30542 1/20 0.31
ALDH1A1 P00352 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2D6 P10635 1/20 0.31
TSHR P16473 1/20 0.31
CYP2C19 P33261 1/20 0.31
NPC1 O15118 1/20 0.31
TP53 P04637 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
PKM P14618 3/20 0.30
PKLR P30613 3/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24334439 1.00 ACLY (0.39) ACLYHTR1AHTR4CHRM1CHRM2
SCHEMBL24333714 0.90 ACLY (0.40) ACLYHTR1AHTR4CHRM1CHRM2
SCHEMBL24333798 0.87 PKLR (0.30) PKLR
SCHEMBL24334286 0.81 F2 (0.32) HTR1AALDH1A1TSHRPKM
SCHEMBL29469635 0.81 F2 (0.32) HTR1AALDH1A1TSHRPKM
SCHEMBL29469655 0.81 CA12 (0.31) CHRM1CHRM2KCNH2MCHR1
SCHEMBL24333606 0.81 CA12 (0.31) CHRM1CHRM2KCNH2MCHR1
SCHEMBL24334433 0.81 HTR1A (0.33) HTR1AADORA2AADORA1NPC1TP53
SCHEMBL24333793 0.79 PKLR (0.34) ALDH1A1TSHRTP53RAB9ASMN1; SMN2
SCHEMBL24333584 0.79 POLB (0.40) ALDH1A1TSHRTP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4229048-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute, Inc. (US) 2023-08-23 EP claimed
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO claimed
EP-4229048-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute, Inc. (US) 2023-08-23 EP disclosed
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed